Clinical Trials & Studies

The study is testing an oral investigational medicine for the treatment of COVID-19, the illness caused by SARS-CoV-2 coronavirus. The trial will evaluate the safety, tolerability, and efficacy of EIDD-2801 to eliminate SARS-CoV-2 viral RNA detection in persons with COVID-19. 

The study is testing an infusion of REGN-COV2, a combination of two antibodies against SARS-CoV-2, the virus that causes COVID-19, to see whether they can: (1) decrease the amount of virus in the body; (2) decrease the length of time the virus is in the body; and (3) decrease the length and severity of COVID-19 illness. The antibodies in this study cannot give you SARS-CoV-2.

The primary objectives of this study are to evaluate the efficacy of remdesivir (RDV) in reducing the rate of hospitalization or death in non-hospitalized participants with early stage COVID-19 and to evaluate the safety of RDV administered in an outpatient setting.

Fred Hutch is recruiting patient with leukemia or related blood disorders who have relapsed after blood or marrow transplant to a phase 1 treatment study. Eligible participants may be offered a new type of cell therapy.

Fred Hutch Survivorship Program is recruiting childhood transplant recipients, parents and caregivers to a study to lean more about what is easy or hard when returning to school after a transplant.

Fred Hutch Survivorship Program is recruiting young adult cancer survivors to a study to learn more about the impact of cancer therapy on employment and work-related quality of life.

We are recruiting participants for a study of the immune system. Help us learn how the immune system of healthy individuals and patients with compromised immune systems respond to an inactivated vaccine.

This 12-week pilot study will research the effects of healthy eating on biomarkers in blood and breast density. You may be eligible for this study if you are female, aged 18-30 and have not had children.

If you are interested in this study, complete a survey first.

Some studies have shown that frequent eating is associated with lower risk for certain diseases, while other studies suggest that eating the standard three meals a day is better. We are recruiting healthy adults between the ages of 18 to 50 to participate in a a study that examines how eating patterns influence health and appetite. 

Some studies have shown that frequent eating is associated with lower risk for certain diseases, while other studies suggest that eating the standard three meals a day is better. We are recruiting healthy adults between the ages of 18 to 50 to participate in a a study that examines how eating patterns influence health and appetite. 

We are currently recruiting about 200 people to participate in our study. We hope that this study may provide information to help with designing a vaccine for Rhinovirus or for other viruses. Rhinoviruses are responsible for causing 30-50% of common colds.  

Prostate Cancer Active Lifestyle (PALS) is enrolling volunteers with low-grade prostate cancer who have chosen active surveillance of their disease. The goal is to learn whether weight loss through diet and exercise can slow the progression of prostate cancer.

We are working to develop vaccines and medicines to prevent and limit malaria. To do this, we need healthy volunteers to take part in our clinical research studies. Read the general criteria and use our screening tool to see if you qualify for a study.

We are seeking both HIV-positive and HIV-negative volunteers for observational studies that help us learn more about the immune system. No medications or vaccines will be given.

We are enrolling HIV-negative volunteers for studies on how the mucosal immune system works and how people become infected with HIV through sex. Participants will make one clinic visit and provide a swabbed sample from their mucous membranes.